Natera and Eledon partner on kidney transplant Phase 3 trial
Go back to Natera and Eledon partner on kidney transplant Phase 3 trial| (NASDAQ: ELDN) | Delayed: 3.02 +0.09 (3.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.93 | 52 Week High | $ | |||
| Open | $2.98 | 52 Week Low | $ | |||
| Day High | $3.06 | P/E | N/A | |||
| Day Low | $2.93 | EPS | $ | |||
| Volume | 1,197,884 | |||||
| (NASDAQ: NTRA) | Delayed: 328.18 +0.51 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $327.67 | 52 Week High | $13.80 | |||
| Open | $323.92 | 52 Week Low | $6.52 | |||
| Day High | $329.05 | P/E | N/A | |||
| Day Low | $323.42 | EPS | $0.00 | |||
| Volume | 968,222 | |||||
